A Vaccine Plus Antiviral Meds Could Conquer Hepatitis C | Hepatitis Central

The latest research & treatment news about Hepatitis C infection, diagnosis, symptoms and treatment.

Menu Search
Previous

Vitamin A: Hepatitis C Foe or Ally?

Back to News Homepage
Next

Unfavorable IL-28 Genotype Benefits from the GI-5005 Hep C Vaccine

A Vaccine Plus Antiviral Meds Could Conquer Hepatitis C

The Editors at Hepatitis Central
December 2, 2010

Print this page

Clinical trials in Oxford are gathering evidence that a therapeutic Hepatitis C vaccine can help defeat the virus when combined with antiviral therapy.

Advances made in developing hepatitis C vaccine

By Aaron Derfel, Postmedia News

November 22, 2010

MONTREAL — Scientists are zeroing in on a promising vaccine to treat hepatitis C, an international symposium was told Friday in Montreal.

Three preliminary clinical trials in England are showing that a so-called therapeutic vaccine can boost the immune response in those infected with the hepatitis C virus.

Still, a viable vaccine is a decade away, said Paul Klenerman, a University of Oxford physician researcher who is conducting the trials.

“Other vaccine trials have been done already, but ours is the first where we’re treating people (with drugs) and giving them the vaccine at the same time,” he said.

Continue reading this entire article:
http://www.montrealgazette.com/health/Advances+made+developing+hepatitis+vaccine/3865544/story.html

No Comments - be the first!
Share
Share
Previous

Vitamin A: Hepatitis C Foe or Ally?

Back to News Homepage
Next

Unfavorable IL-28 Genotype Benefits from the GI-5005 Hep C Vaccine

Requirements for using and reposting articles

Comments

HepatitisCentral.com provides information regarding hepatitis and liver disease. Comments are available to the community in order to discuss these topics and obtain answers to questions through community members. The Editors at HepatitisCentral.com will not be responding to questions or comments posed in article comments.